Aspirin use is low among United States outpatients with coronary artery disease

Circulation

Volumn 101, Issue 10, 2000, Pages 1097-1101

  Stafford, Randall S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Aspirin; Heart diseases; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; SULFINPYRAZONE; TICLOPIDINE; WARFARIN;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG USE; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; OUTPATIENT; PRIORITY JOURNAL; SEX; UNITED STATES;

EID: 0034646206     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.10.1097     Document Type: Article

References (47)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:82-105.
2. Hennekens CH. Aspirin in the treatment and prevention of cardiovascular disease. Annu Rev Public Health. 1997;18:37-49.
3. Hennekens CH, Jonas MA, Buring JE. The benefits of aspirin in acute myocardial infarction: still a well-kept secret in the United States. Arch Intern Med. 1994;154:37-39.
4. Hennekens CH, Dyken ML, Fuster V. Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1997;96: 2751-2753.
5. Second International Study of Infarct Survival (ISIS-2) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 1988;2:349-360.
6. Smith SC, Blair SN, Criqui MH, Fletcher GF, Fuster V, Gersh BJ, Gotto AM, Gould KL, Greenland P, Grundy SM, Hill MN, Hlatky MA, Houston-Miller N, Krauss RM, LaRosa J, Ockene IS, Oparil S, Pearson TA, Rapaport E, Starke RD. Preventing heart attack and death in patients with coronary disease. Circulation. 1995;92:2-4.
7. Ayanian JZ, Guadagnoli E, McNeil BJ, Cleary PD. Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians. Arch Intern Med. 1997;157: 2570-2576.
8. Bratzler DW, de Leon AC Jr. Johnson MC, Oehlert WH, Slagle RC, Murray CK, Bumpas LJ, Webb J. The Cooperative Cardiovascular Project in Oklahoma. J Okla State Med Assoc. 1997;90:219-227.
9. Ellerbeck EF, Jencks SF, Radford MJ, Kresowik TF, Craig AS, Gold JA, Krumholz HM, Vogel RA. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509-1514.
10. Krumholz HM, Radford MJ, Ellerbeck EF, Hennen J, Meehan TP, Petrillo M, Wang Y, Kresowik TF, Jencks SF. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries: patterns of use and outcomes. Circulation. 1995;92:2841-2847.
11. Krumholz HM, Radford MJ, Ellerbeck EF, Hennen J, Meehan TP, Petrillo M, Wang Y, Jencks SF. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med. 1996;124:292-298.
12. Lamas GA, Pfeffer MA, Hamm P, Wertheimer J, Rouleau JL, Braunwald E. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? N Engl J Med. 1992;327: 241-247.
13. Pagley PR, Yarzebski J, Goldberg R, Chen Z, Chiriboga D, Dalen P, Gurwitz J, Alpert JS, Gore JM. Gender differences in the treatment of patients with acute myocardial infarction: a multihospital, community-based perspective. Arch Intern Med. 1993;153:625-629.
14. Col NF, McLaughlin TJ, Soumerai SB. Hosmer DW Jr, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. The impact of clinical trials on the use of medications for acute myocardial infarction: results of a community-based study. Arch Intern Med. 1996;156:54-60.
15. Eccles M, Bradshaw C. Use of secondary prevention against myocardial infarction in the north of England. BMJ. 1991;302:91-92.
16. Montague TJ, Wong RY, Burton JR, Bay KS, Catellier DJ, Teo KK. Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90. Can J Cardiol. 1992;8:596-600.
17. Krumholz HM, Philbin DM Jr, Wang Y, Vaccarino V, Murillo JE, Therrien ML, Williams J, Radford MJ. Trends in the quality of care for Medicare beneficiaries admitted to the hospital with unstable angina. J Am Cell Cardiol. 1998;31:957-963.
18. Giugliano RP, Camargo CA Jr, Lloyd-Jones DM, Zagrodsky JD, Alexis JD, Eagle KA, Fuster V, O'Donnell CJ. Elderly patients receive less aggressive medical and invasive management of unstable angina: potential impact of practice guidelines. Arch Intern Med. 1998;158:1113-1120.
19. Bowker TJ, Clayton TC, Ingham J, McLennan NR, Hobson HL, Pyke SD, Schofield B, Wood DA. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart. 1996;75:334-342.
20. EUROASPIRE Study Group. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J. 1997;18:1569-1582.
21. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
22. Shahar E, Folsom AR, Romm FJ, Bisgard KM, Metcalf PA, Crum L, McGovern PG, Hutchinson RG, Heiss G. Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1996;131:915-922.
23. McCartney P, Macdowall W, Thorogood M. A randomised controlled trial of feedback to general practitioners of their prophylactic aspirin prescribing. BMJ. 1997;315:35-36.
24. Campbell NC, Thain J. Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ. 1998;316:1430-1434.
25. National Center for Health Statistics. Public Use Data Documentation: 1980 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service; 1982.
26. National Center for Health Statistics. Public Use Data Documentation: 1981 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service; 1983.
27. National Center for Health Statistics. Public Use Data Documentation: 1985 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service: 1987.
28. National Center for Health Statistics. Public Use Data Documentation: 1989 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service; 1991.
29. National Center for Health Statistics. Public Use Data Documentation: 1990 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics. US Public Health Service; 1992.
30. National Center for Health Statistics. Public Use Data Documentation: 1991 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service; 1993.
31. National Center for Health Statistics. Public Use Data Documentation: 1992 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service; 1994.
32. National Center for Health Statistics. Public Use Data Documentation: 1993 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service; 1995.
33. National Center for Health Statistics. Public Use Data Documentation: 1994 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service; 1996.
34. National Center for Health Statistics. Public Use Data Documentation: 1995 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service; 1997.
35. National Center for Health Statistics. Public Use Data Documentation: 1996 National Ambulatory Medical Care Survey. Hyattsville, F MD: National Center for Health Statistics, US Public Health Service; 1998.
36. DeLozier JE. The design and methods of the National Ambulatory Medical Care Survey. Med Group Manage. 1974;12:5-7.
37. Potthoff RF, Woodbury MA, Manton KG. Equivalent sample size and equivalent degrees of freedom: refinements for inference using survey weights under superpopulation models. J Am Stat Soc. 1992;87: 382-396.
38. National Center for Health Statistics. International Classification of Diseases, Ninth Revision, Clinical Modification, Third Edition, Volume 1. Washington, DC: US Public Health Service; 1989: DHHS publication No. (PHS) 89-1260.
39. Schneider D, Appleton L, McLemore T. Reason for Visit Classification for Ambulatory Care. Hyattsville, Md: National Center for Health Statistics: 1979: Vital Health Stat, Series No. 2 (78).
40. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: Wiley and Sons; 1981.
41. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: Wiley-lnterscience; 1989.
42. Statistical Analysis System. SAS/STAT User's Guide, Version 6. 4th ed. Cary, NC: Statistical Analysis System; 1990.
43. Ayanian JZ, Epstein AM. Differences in the use of procedures between men and women hospitalized for coronary heart disease. N Engl J Med. 1991;325:221-225.
44. Gatsonis CA, Epstein AM, Newhouse JP, Normand SL, McNeil BJ. Variations in the utilization of coronary angiography for elderly patients with an acute myocardial infarction: an analysis using hierarchical logistic regression. Med Care. 1995;33:625-642.
45. DeBusk RF. MULTIFIT: a new approach to risk factor modification. Cardiol Clin. 1996;14:143-157.
46. Pearson TA, McBride PE, Miller NH, Smith SC. Task Force 8: organization of preventive cardiology service. J Am Coll Cardiol. 1996;27:1039-1047.
47. HEDIS 3.0, Volume 2: Technical Specifications. Washington, DC: National Committee for Quality Assurance; 1997.